"10.1371_journal.pone.0146822","plos one","2016-02-09T00:00:00Z","Erik R Dubberke; Margaret A Olsen; Dustin Stwalley; Ciarán P Kelly; Dale N Gerding; Yinong Young-Xu; Cedric Mahé","Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America; Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, United States of America; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America; Edward Hines Jr. Veterans Affairs Hospital, Hines, Illinois, and Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, United States of America; Department of Psychiatry, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America; Sanofi-Pasteur, Lyon, France","Conceived and designed the experiments: ERD MAO. Performed the experiments: ERD MAO DS. Analyzed the data: ERD MAO DS. Contributed reagents/materials/analysis tools: ERD MAO DS CPK DNG YYX CM. Wrote the paper: ERD MAO DS CPK DNG YYX CM.","ERD reports grants and personal fees from Sanofi-Pasteur, during the conduct of the study; grants from Microdermis, personal fees and other from Merck, personal fees and other from Rebiotix, outside the submitted work. MAO reports grants from Sanofi Pasteur, during the conduct of the study; personal fees from Sanofi Pasteur, personal fees from Pfizer, outside the submitted work. DS reports other from Abbott Laboratories, other from Bristol-Myers Squibb, outside the submitted work. CPK reports personal fees from Astellas, personal fees from Novartis, personal fees from MedImmune, personal fees from Merck, grants and personal fees from Sanofi-Pasteur, grants from CSL-Behring, grants from Merck, personal fees from QuantiaMed, outside the submitted work. In addition, CPK has a patent Passive immunotherapy for CDI using IgA pending. DNG holds patents for the treatment and prevention of CDI licensed to ViroPharma/Shire, is a consultant for Merck, Shire, Rebiotix, Sanofi Pasteur and Actelion and holds research grants from CDC and United States Department of Veterans Affairs Research Service. YYX reports personal fees from Sanofi-Pasteur, during the conduct of the study; personal fees from Sanofi-Pasteur, outside the submitted work. CM reports other from Sanofi Pasteur, outside the submitted work. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2016","02","Erik R Dubberke","ERD",7,TRUE,2,3,3,7,TRUE,TRUE,FALSE,0,NA,FALSE
